Form 483

Deciem Inc. Form 483, 2026-04-02

FDA issued a Form 483 to Deciem Inc. on 2026-04-02 with 5 public-safe observations.

483· Form 483 issuedHuman Drugs5 observations

Deciem Inc. · Etobicoke, Canada · Issued April 2, 2026

Overview

  • 5 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

2 Apr 2026
21 CFR 211.170(b)

Annual visual exams of drug products

Cited by Wayne D Mcgrath

2 Apr 2026
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Wayne D Mcgrath

2 Apr 2026
21 CFR 211.67(b)

Written procedures not established/followed

Cited by Wayne D Mcgrath

2 Apr 2026
21 CFR 211.68(b)

Backup file not maintained

Cited by Wayne D Mcgrath

2 Apr 2026
21 CFR 211.68(b)

Computer control of master formula records

Cited by Wayne D Mcgrath

Inspected site

DIDeciem Inc.Etobicoke, Canada

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.68(b)Cited across public-safe Form 483 observations2x
21 CFR 211.170(b)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 5 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere